None listed
Conditions
Brief summary
Cancer diseases appear today as a particularly important issue due to health, psychological and social consequences. In Poland, as in other European countries, breast cancer is the most frequently diagnosed cancer among women. The peak incidence falls on the age of 65-69, however, the number of cases diagnosed in younger women is increasing. The greatest increase in incidence is observed after the age of 40. This means that breast cancer more and more often affects women who are fully active in professional, family and social life. Cancer is one of the most traumatic experiences in human life. There are unknown emotions associated with the diagnosis of cancer, its treatment and fear related to the prognosis. This usually has a negative impact on psychophysical well-being. The use of virtual reality (VR) in medicine is gaining more and more supporters. Both immersive and non-immersive virtual reality find their application, e.g. in surgery, rehabilitation, neurology and play a special role in educating future doctors. VR allows you to simulate surgical procedures and supports the course of complex operations, it is used in rehabilitation to improve cognitive and motor functions, it is also a popular tool in psychology because it can be used as a relaxation therapy. The main difference between immersive and non-immersive VR is the amount of stimuli provided to the user. Immersion technology allows you to affect almost all senses and completely isolate the patient from the real world. Virtual reality seems to be a new and effective tool that distracts the patient from medical procedures, which can also contribute to improving the quality of life and reducing the undesirable effects of oncological treatment, translating into the promotion of an active lifestyle in this area among oncological patients. The characteristics of cancer and VR therapy seem to be matched in terms of expectations and possibilities. By analyzing current scientific reports, virtual reality systems may be the optimal tool in reducing the negative effects of cancer, and research goals result directly from the available knowledge.
Interventions
The intervention based on the VRTierOne system will be used as an additional intervention. Participation in the experimental group does not result in the loss of other available forms of therapy. 8, 20-minute therapeutic sessions are planned, carried out over 2 weeks. Patients will be supervised by physiotherapists trained to use the system by the manufacturer and a psychotherapist, substantive care covering the psychophysical condition of patients will be provided by Professors of the Universit
The intervention based on the VRTierOne system will be used as an additional intervention. Participation in the experimental group does not result in the loss of other available forms of therapy. 8, 20-minute therapeutic sessions are planned, carried out over 2 weeks. Patients will be supervised by physiotherapists trained to use the system by the manufacturer and a psychotherapist, substantive care covering the psychophysical condition of patients will be provided by Professors of the University of Physical Education in Wroclaw, medical care covering the general health of patients by breast unit. Sessions are held in the form of individual meetings, in a room excluded from use for purposes other than scientific and therapeutic during the research period. The session starts with putting on virtual reality (VR) goggles with headphones. After starting the session, the patient is always in the same virtual environment (garden) and listens to the voice of the therapist conducting therapy in the Ericksonian style. In some sessions, the patient receives a movement task for the upper limb consisting of drawing. The system automatically marks the presence of patients and by entering an individual patient code each time directs to the next session until the end of therapy in session number 8.
Sponsors
Iwona Malicka - promoter
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Malignant breast cancer, no cognitive impairments, written consent
Exclusion criteria
None
Outcome results
None listed